Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang(Zhejiang Cancer Hospital), Fan Xia(Shanghai Medical Information Center), Nan Zheng(Changchun University of Science and Technology), Chengzhi Zhou(First Affiliated Hospital of Guangzhou Medical University), Rongbo Lin(Fujian Provincial Cancer Hospital), Yongheng Li(Fudan University Shanghai Cancer Center), Ping Zhan(Nanjing Medical University), Tangfeng Lv(Nanjing University), Chuanhao Tang(Peking University), Lingfeng Min(Northern Jiangsu People's Hospital), Jinpu Yu(Tianjin Medical University Cancer Institute and Hospital), Jin Zhou(Sichuan Cancer Hospital), Zongyang Yu(Fujian Medical University), Xingxiang Pu(Central South University), Dongqing Lv(Wenzhou Medical University), Junli Xue(Shanghai East Hospital), Bin Lian(Peking University), Feng Wang(Sun Yat-sen University), Liyun Miao(Nanjing Drum Tower Hospital), Jingping Yuan(Renmin Hospital of Wuhan University), Zhansheng Jiang(Tianjin Medical University Cancer Institute and Hospital), Wen‐Zhao Zhong(Guangdong Academy of Medical Sciences), Chuangzhou Rao(Ningbo No. 2 Hospital), Rui Meng(Union Hospital), Qian Wang(Nanjing University of Chinese Medicine), Yu Chen(Hunan Normal University), Zhijie Wang(Affiliated Hospital of Qingdao University), Rui Zhang(Ningxia Medical University), Jingjing Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Weifeng Liu(Eastern Hepatobiliary Surgery Hospital), Xiaoyan Li(Beijing Tian Tan Hospital), Aijun Liu(Nanchang University), Li Wen(Chinese Academy of Medical Sciences & Peking Union Medical College), Junping Zhang(Huaqiao University), Yongchang Zhang(Central South University), Long Huang(Second Affiliated Hospital of Nanchang University), Shirong Zhang(Hangzhou First People's Hospital), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Qian Chu(Tongji Hospital), Jingxun Wu(First Affiliated Hospital of Xiamen University), Hongbing Liu(Nanjing Medical University), Hong Qiu(Tongji Hospital), Anwen Liu(Nanchang University), Lili Mao(Ministry of Education), Xiuyu Cai(Sun Yat-sen University), Ziming Li(Shanghai Chest Hospital), Xuewen Liu(Central South University), Zhengfei Zhu(Shanghai Medical College of Fudan University)
Cited by 12
Related Papers
Notch signaling pathway: architecture, disease, and therapeutics
|Signal Transduction and Targeted Therapy|2022|1k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer
|International Journal of Biological Sciences|2021|295